woman drawing chemical chain on glass

Pharma Services

NeoGenomics offers lab services for oncology clinical trials

Learn more

NeoGenomics booth display at trade show event

COVID-19

Precision Medicine during this Crisis

NeoGenomics and other organizations in the healthcare community unite to form COVID-19 testing industry consortium.

Click here to view

Latest

Presented:
Source: Webinar

Molecular Tumor Board

Breast Cancer Series
Presented:
Source: Webinar

The Expanding Role of Biomarkers in NSCLC

Learn More About Emerging Biomarkers Like KRAS G12C
Presented:
Source: Webinar

Molecular Tumor Board

Lung Cancer Series
Presented:
Source: Webinar

PIK3CA Mutations in Advanced Breast Cancer

The Vital Role of Tissue and Plasma Companion Diagnostics
Presented:
Source: Webinar

Tracking TRK with IHC

Today’s Diagnostic Algorithms for NTRK Testing

New Tests

Image
IHC icon
Available: November 20, 2020
Methodology: Immunohistochemistry (IHC)

PD-L1 22C3 FDA (KEYTRUDA®) for TNBC (Breast)

PD-L1 IHC 22C3 pharmDx is a qualitative immunohistochemical assay using Monoclonal Mouse Anti-PD-L1…
Image
IHC icon
Available: October 22, 2020
Methodology: Immunohistochemistry (IHC)

Ki67 NET

Ki67 is a nuclear protein expressed in proliferating cells. Ki67 is expressed in all phases of the…
Image
IHC icon
Available: September 28, 2020
Methodology: Immunohistochemistry (IHC)

PIT1

PIT1 is a transcription factor critical in the normal development of the anterior pituitary. IHC…
Image
Molecular icon
Available: September 23, 2020
Methodology: Molecular

Full Focus Cancer Panel (Germline)

Testing is performed by Fulgent Genetics. Patient and physician or genetic counselor signatures on…
Image
IHC icon
Available: September 2, 2020
Methodology: Immunohistochemistry (IHC)

DLL3

Delta-like protein 3 (DLL3) expression is regulated by ASCL1, a transcription factor that is…